The evaluation of potential toxicological effects of all pharmaceuticals is
required prior to product registration. The safety evaluation of these products
is performed in mammalian systems, for which extensive background data can be
of great value in the evaluation of responses observed in the studies. Huntingdon
Life Sciences, with over fifty years experience in this work is ideally placed
to assist you with this testing.
We have the capacity and a wide variety of the necessary skills, enabling us
to design and conduct all study types in accordance with the requirements of
the product under test. For example, all the common dosing routes, such as dermal,
inhalation, intravenous injection and oral are available, as well as some other
specialist routes such as vascular infusion. All areas of regulatory toxicology
enabling a Phase III clinical trial can be covered:
Together with our extensive support departments, we provide the full comprehensive
package of tests required for registration and market authorisation, which ultimately
helps speed your product to market.
|
